AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE: 100 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
100
Total FAERS Reports
22 (22.0%)
Deaths Reported
54
Hospitalizations
100
As Primary/Secondary Suspect
26
Life-Threatening
2
Disabilities
First Report: 2008 · Latest Report: 20210616
What Are the Most Common AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE Side Effects?
#1 Most Reported
Therapeutic product effect incomplete
34 reports (34.0%)
#2 Most Reported
Dyspnoea
34 reports (34.0%)
#3 Most Reported
Pulmonary embolism
32 reports (32.0%)
All AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 34 | 34.0% | 16 | 20 |
| Therapeutic product effect incomplete | 34 | 34.0% | 14 | 33 |
| Asthma | 32 | 32.0% | 16 | 18 |
| Obstructive airways disorder | 32 | 32.0% | 16 | 18 |
| Pulmonary embolism | 32 | 32.0% | 16 | 18 |
| Respiratory symptom | 31 | 31.0% | 15 | 17 |
| Wheezing | 31 | 31.0% | 14 | 16 |
| Female genital tract fistula | 30 | 30.0% | 0 | 17 |
| Chronic sinusitis | 29 | 29.0% | 0 | 17 |
| Headache | 22 | 22.0% | 0 | 18 |
| Nausea | 22 | 22.0% | 0 | 20 |
| Pain in extremity | 22 | 22.0% | 16 | 20 |
| Pain | 21 | 21.0% | 0 | 19 |
| Abdominal pain | 20 | 20.0% | 0 | 20 |
| Malaise | 20 | 20.0% | 0 | 19 |
| Antineutrophil cytoplasmic antibody positive | 19 | 19.0% | 16 | 18 |
| Anxiety | 19 | 19.0% | 16 | 18 |
| Arteriosclerosis | 19 | 19.0% | 16 | 18 |
| Arteriosclerosis coronary artery | 19 | 19.0% | 16 | 18 |
| Capillaritis | 19 | 19.0% | 16 | 18 |
Who Reports AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE Side Effects? Age & Gender Data
Gender: 52.6% female, 47.4% male. Average age: 63.5 years. Most reports from: CA. View detailed demographics →
Is AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 0 |
| 2014 | 3 | 0 | 2 |
| 2015 | 7 | 1 | 2 |
| 2016 | 4 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 3 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
What Is AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 71 |
| Helicobacter infection | 6 |
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs Alternatives: Which Is Safer?
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMOXICILLIN\CLAVULANATE
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMOXICILLIN\CLAVULANIC ACID
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMOXICILLIN\OMEPRAZOLE\RIFABUTIN
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMPHETAMINE ASPARTATE\AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMPHETAMINE\DEXTROAMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMPHOTERICIN B
AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE vs AMPHOTERICIN B\DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-\DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-
Official FDA Label for AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE
Official prescribing information from the FDA-approved drug label.